홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Cesium carbonate → HCID 59519096, 화합물

HRID 1161857
인쇄

반응식

HRID 1161857 반응식
C1(P(C2C=CC=CC=2)C2C=CC3C(=CC=CC=3)C=2C2C3C(=CC=CC=3)C=CC=2P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.Br[C:48]1[CH:49]=[C:50]2[C:55](=[CH:56][CH:57]=1)[N:54]=[C:53]([C:58]1[CH:63]=[CH:62][CH:61]=[C:60]([Cl:64])[CH:59]=1)[N:52]([CH2:65][C:66]([NH:68][C:69]([CH3:72])([CH3:71])[CH3:70])=[O:67])[C:51]2=[O:73].[C:74]([O:78][C:79]([N:81]1[CH2:87][CH2:86][CH2:85][NH:84][CH2:83][CH2:82]1)=[O:80])([CH3:77])([CH3:76])[CH3:75].C(=O)([O-])[O-].[Cs+].[Cs+]>C([O-])(=O)C.[Pd+2].C([O-])(=O)C.O1CCOCC1.C1(C)C=CC=CC=1>[C:74]([O:78][C:79]([N:81]1[CH2:87][CH2:86][CH2:85][N:84]([C:48]2[CH:49]=[C:50]3[C:55](=[CH:56][CH:57]=2)[N:54]=[C:53]([C:58]2[CH:63]=[CH:62][CH:61]=[C:60]([Cl:64])[CH:59]=2)[N:52]([CH2:65][C:66](=[O:67])[NH:68][C:69]([CH3:72])([CH3:71])[CH3:70])[C:51]3=[O:73])[CH2:83][CH2:82]1)=[O:80])([CH3:77])([CH3:75])[CH3:76]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 4

HCID 10796Cesium carbonateHCID 634876Binap, (A+-)-HCID 2756058Tert-butyl 1,4-diazepane-1-carboxylateHCID 595190572-[6-bromo-2-(3-chlorophenyl)-4-oxo-4H-quinazolin-3-yl]-N-tert-butylacetamide

생성물 1

HCID 59519096HCID 59519096, 화합물수율 46.7%

시약·촉매·용매 3

HCID 167845palladium(II) acetate촉매
HCID 1140Toluene용매
HCID 312751,4-Dioxane용매

반응 조건

온도
80 °C

실험 절차

Racemic-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (5 mg, 0.009 mmol) and anhydrous toluene (0.5 mL) was heated in a microwave vial with stirring at 80° C. under an Argon atmosphere until a homogeneous milky solution was obtained (˜5 min). This solution was cooled to room temperature and palladium(II) acetate (2 mg, 0.006 mmol) was added. After stirring at room temperature for 2 min., 2-[6-bromo-2-(3-chlorophenyl)-4-oxo-4H-quinazolin-3-yl]-N-tert-butylacetamide (INTERMEDIATE VI.1) (67 mg, 0.15 mmol), tert-butyl-1-homopiperazinecarboxylate (35 μL, 0.18 mmol) and freshly ground cesium carbonate (68 mg, 0.21 mmol) were added to the red solution. Anhydrous dioxane (0.2 mL) was added to rinse down solid left on the side of the vial. The vial was capped and heated in a microwave at 120° C. for 40 min. The reaction mixture was diluted with DCM (3 mL), filtered and the filtrate concentrated in vacuo. This crude product was purified by preparative TLC on silica gel with hexane:EtOAc:CH2Cl2 (1:1:1, v/v) as eluent to give 4-[3-(tert-butylcarbamoylmethyl)-2-(3-chlorophenyl)-4-oxo-3,4-dihydroquinazolin-6-yl]perhydro-1,4-diazepine-1-carboxylic acid tert-butyl ester (INTERMEDIATE VIII.1) (38.9 mg, 0.07 mmol, 46%) as a yellow solid.

후처리

  1. customwas obtained (˜5 min)
  2. temperatureThis solution was cooled to room temperature
  3. stirringAfter stirring at room temperature for 2 min.
  4. washto rinse down solid
  5. waitleft on the side of the vial
  6. customThe vial was capped
  7. temperatureheated in a microwave at 120° C. for 40 min
  8. additionThe reaction mixture was diluted with DCM (3 mL)
  9. filtrationfiltered
  10. concentrationthe filtrate concentrated in vacuo
  11. customThis crude product was purified by preparative TLC on silica gel with hexane:EtOAc:CH2Cl2 (1:1:1

출처 및 근거

ORD 기록
ord-720e0ebb9a8d44139376a7e021c74072
출처 데이터셋
uspto-grants-2010_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07820649B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트